Related News
Home 禄 Metro 禄 Health and Science
Quintiles to open bio-medicine lab in Shanghai
By Cai Wenjun |
June 18, 2012, Monday
|
Online Edition
Online Edition
THE state-owned Shanghai Clinical Research Center today signed an agreement with the US-based Quintiles, the world's largest bio-pharmaceutical services provider, to set up a joint venture lab to boost new drug development in China.
Chronic diseases common among elderly people will be a focus of research at the new laboratory in Shanghai, said Qunintiles, which will invest US$14 million in its China headquarters and local lab in the Fenglin Life Science Park in Xuhui District and hire about 450 employees in the next five years.
In addition to developing new drugs, the lab will also tap the potentials of traditional Chinese medicine in pharmaceutical research and development.
Chronic diseases common among elderly people will be a focus of research at the new laboratory in Shanghai, said Qunintiles, which will invest US$14 million in its China headquarters and local lab in the Fenglin Life Science Park in Xuhui District and hire about 450 employees in the next five years.
In addition to developing new drugs, the lab will also tap the potentials of traditional Chinese medicine in pharmaceutical research and development.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
